Category: Astrazeneca

Australia Secures 1 Million AstraZeneca Doses for Papua New Guinea

Australian Trade Minister Dan Tehan has secured one million COVID-19 vaccine doses for Papua New Guinea (PNG), which neighbours Australia to the north, and has been experiencing a severe outbreak. The arrangement was secured after Tehan approached AstraZeneca directly while visiting Europe and the United Kingdom to shore up Australia’s vaccine supplies. The one million…


Sri Lanka Reports 6 Cases of Blood Clots Among 925,000 AstraZeneca Vaccine Recipients, 3 Dead

NEW DELHI—Sri Lanka has found six cases of blood clots among recipients of the AstraZeneca COVID-19 vaccine, three of whom have died, Health Minister Pavithra Waniarachchi told parliament on Wednesday. Nearly a million people, 925,000 of the country’s 21 million population, have been given the first dose of the Indian-made vaccine in the country. No announcement of…


Brisbane Man in Hospital With Blood Clots 3 Days After Pfizer Jab

Nine News has reported that a 40-year-old Brisbane man was rushed to hospital with blood clots three days after he received the Pfizer jab. Queensland Health did not immediately confirm whether there is a link between the man’s health condition and the Pfizer vaccine. It is likely too early to know. However, last week a…


Brisbane Cop in Hospital With Blood Clots 3 Days After Pfizer Jab

A Brisbane police officer is reportedly being treated in hospital for blood clots three days after he received the Pfizer jab. The 40-year-old man’s job was to patrol at Queensland’s quarantine hotels, Nine News reported. Queensland Health did not immediately confirm whether there is a link between the man’s health condition and the Pfizer vaccine. It…


EU Regulator Finds ‘Possible Link’ Between J&J Vaccine and Blood Clots

The European Union’s medicines regulator said on Tuesday that there is a “possible link” between Johnson & Johnson’s COVID-19 vaccine and blood clots, but said its “overall benefit-risk remains positive.” At a meeting on Tuesday, the safety committee of the European Medicines Agency (EMA) concluded that a warning about unusual blood clots should be added…


AstraZeneca Could Have COVID-19 Vaccine Against Variant by End of 2021: Austrian Newspaper

ZURICH—A modified version of AstraZeneca’s COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday. Sarah Walters, AstraZeneca’s Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing…


Alberta Confirms Country’s Second Blood Clot After AstraZeneca Vaccine Dose

Alberta has confirmed a rare blood clot case in a patient who received the Oxford-AstraZeneca vaccine, the province’s chief medical officer of health announced on Saturday. Dr. Deena Hinshaw said the male patient, who is in his 60s and recovering, marks the second Canadian case of the blood clot disorder known as vaccine-induced immune thrombotic…


EU Throws Weight Behind Pfizer/BioNTech and New Technology

BRUSSELS—In a stinging rebuke to pharma giant AstraZeneca on Wednesday, the European Union announced plans to negotiate a massive contract extension for Pfizer/BioNTech’s COVID-19 vaccine, insisting the 27-nation bloc had to go with companies that had shown their value in the pandemic. “We need to focus on technologies that have proven their worth,” said EU…


European Medicines Agency Approves AstraZeneca Vaccine, but Concerns Remain

Commentary Following 20 million AstraZeneca jabs so far administered in the UK there have been 79 blood clot cases recorded, from which 19 deaths have occurred. The UK government’s Medicines and Healthcare Products Regulatory Agency (MHRA) concludes that roughly one in 100,000 young adults are likely to develop these types of blood clots after taking…


Blood Clots May Be Linked to AstraZeneca Vaccine but Still Very Rare: Health Canada

OTTAWA—Health Canada says a new and extremely rare blood clotting syndrome may be linked to Oxford-AstraZeneca vaccine but the benefits of the vaccine still far outweigh the risks. The conclusions come after the department’s drug regulatory experts completed a review of safety data, and are in line with those issued in Europe and the United…